September 3, 2014
Why invest in R&D for HIV, TB and malaria? Because it’s good for global health, and good for Europe
In this post, Eoghan Walsh—communications officer at Deutsche Stiftung Weltbevoelkerung (DSW)—writes about the need for Europe to increase financial and political support for efforts aimed at creating new ways to tackle diseases such as HIV and AIDS, tuberculosis (TB) and malaria.